Auszug
Die Dermatomyositis ist eine systemische entzündliche Bindegewebserkrankung unklarer Ätiologie, deren Hauptmanifestationen eine Entzündung der Muskulatur und charakteristische Hauterscheinungen sind. Die Pathogenese kann wahrscheinlich auf eine Vaskulopathie zurückgeführt werden.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Al-Maouf S, Al-Mazyed A, Bahabri S (2000) Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolon and methotrexate. Clin Rheumatol 19: 138–141
Al-Mayouf SM, Laxer RM, Schneider R et al. (2000) Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety. J Rheumatol 27: 2498–2503
Ambler GR, Chaitow J, Rogers M et al. (2005) Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rheumatol 32: 1837–1839
Ansell BM (1984) Management of polymyositis and dermatomyositis. Clin Rheum Dis 10: 205–213
Artlett CM, Ramos R, Jiminez SA et al. (2000) Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Childhood Myositis Heterogeneity Collaborative Group. Lancet 356: 2155–2156
Bitnum S, Daeschner CWJ, Travis LB et al. (1964) Dermatomyositis. J Pediatr 64: 101–131
Bloom BJ, Tucker L, Miller LC, Schaller JG (1995) Von Willebrand factor in juvenile dermatomyositis. J Rheumatol 22: 320–325
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292: 344–402
Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292: 403–407
British Medical Research Council (1981) Aids to the examination of the peripheral nervous system; Memorandum no. 45. Her Majesty’s Stationery Office, London.
Brown VE, Pilkington CA, Feldman BM et al. on behalf of the network for juvenile dermatomyositis, a working party of the Paediatric Rheumatology European Society (PreS) (2006) An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM). Rheumatology (Oxford)
Cassidy JT et al. (eds) (2005) Textbook of pediatric rheumatology, 5th edn. Saunders, Philadelphia
Cherin P, Herson S, Wechsler B et al. (1991) Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 91: 162–168
Christensen ML, Pachman LM, Schneiderman R et al. (1986) Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 29: 1365
Crowne WE, Bove KE, Levinson JE et al. (1982) Clinical and pathogenetic implications of histopathology in childhood polydermatomyositis. Arthritis Rheum 25: 126–139
Dalakas MC, Illa I, Dambrosia JM et al. (1994) A controlled trial of highdose intravenous immuneglobulin infusions as treatment for dermatomyositis. New Engl J med 330(19): 1392–1402
Dubowitz V. (1976) Treatment of dermatomyositis in childhood. Arch Dis Child 51: 494–500
Esiri MM, MacLennan IC, Hazleman BL (1973) Lymphocyte sensivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol 14: 25–35
Falcini F, Calzolari A, Generini S et al. (2000) Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. Clin Exp Rheumatol 18: 643–646
Feldman BM, Ayling-Campos A, Luy L et al. (1995) Measuring disability in juvenile dermatomyositis: validity of the childhood assessment questionnaire. J Rheumatol 22: 316–331
Foeldvari I, Ruperto N, Dressler F et al. (2001) Paediatric Rheumatology International Trials Organisation. The German version of the childhood health assessment questionnaire (CHAQ) and the child health questionnaire (CHQ). Clin Exp Rheumatol 19(Suppl 23): S71–75
Fujikawa S, Okuni M (1997) A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 39: 242–244
Goncaleves FG, Chimelli I, Sallum AM et al. (2002) Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis. J Rheumatol 29: 1301–1307
Guzman J, Petty RE, Malleson PN (1994) Monitoring disease activity in juvenile dermatomyositis: The role of von Willebrand factor and muscle enzymes. J Rheumatol 21: 739–743
Harati Y, Niakan E, Bergman EW (1986) Childhood dermatomyositis in monozygotic twins. Neurology 36: 721
Heckmatt J, Hasson N, Saunders C et al. (1989) Cyclosporine in juvenile dermatomyositis. Lancet 1: 1063–1066
Hirsch TJ, Enlow RW, Bias WB et al. (1981) HLA-D related (DR) antigens in vanous kinds of myositis. Hum Immunol 3: 181–186
Hoffman EP, Rao D, Pachman LM (2002) Clarifying the boundaries between the inflammatory and dystrophic myopathies insights from molecular diagnostics and microarrays. Rheum Dis Clin North Am 28: 743–757
Huang JL (1996) Juvenile dermatomyositis associated with partial lipodystrohy. Br J Clin Pract 50: 112–113
Huang JL (1999) Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy. Clin Exp Rheumatol 17: 621–624
Huber AM, Lang B, LeBlanc CM et al. (2000) Medium-and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 43: 541–549
Huemer C, Kitson H, Malleson PN et al. (2001) Lipodystrophy in patients with juvenile dermatomyositis-evaluation of clinical and metabolic abnormalities. J Rheumatol 28: 610–615
Huppertz HI (1999) Treatment of juvenile dermatomyositis with high-dose oral steroids or with steroid-pulse-therapy plus low dose oral steroids. Ann Rheum Dis 58(Suppl): 345
Huppertz HI (2001) In: Wahn V, Oppermann J, Huppertz HI, Zepp F (Hrsg) Rheumatische Erkrankungen im Kindes-und Jugendalter. Hans Marseille, München
Jacobs JC (1977) Methotrexate and azathioprine treatment of childhood dermatomyositis. Pediatrics 59: 212–218
Kaipiainen-Seppanen O, Savolainen A (1996) Incidence of chronic juvenile rheumatic diseases in Finland during 1980–1990. Clin Exp Rheumatol 14: 441–444
Kane D, Grassi W, Sturrock R, Balint PV (2004) Musculoskeletal ultrasound-a stat of the art review in rheumatology. Rheumatology (Oxford) 43: 829–838
Kimball AB, Summers RM, Turner M et al. (2000) Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Arthritis Rheum 43: 1866–1873
Lovell DJ, Lindsley CB, Rennenbohm RM et al. (1999) Development of validated disease avtivity and damage indices for the juvenile idiopathic inflammatory myopathies: II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 42: 2213–2219
Maillard SM, Wilkinson N, Riley P et al. (2002) The treatment of persistent idiopathic inflammatory myositis with anti-TNFa therapy. Arthritis Rheum 46(Suppl): S307
Mendez EP, Lipton R, Ramsey-Goldman R et al. (2003) US, incidence of juvenile dermatomyositis, 1995–1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 49: 300–305
Miller ML, Smith RL, Abbott KA et al. (2002) Use of etanercept in chronic juvenile dermatomyositis (JDM). Arthritis Rheum 46(Suppl.): S306
Montecucco C, Ravelli A, Caporali R et al. (1990) Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 8: 193–196
Pachman LM, Cooke N (1980) Juvenile dermatomyositis a clinical and immunologic study. J Pediatr 96: 226–234
Pachman LM, Hayford JR, Hochberg MC et al. (1992) Seasonal onset in juvenile dermatomyositis (JDMS): an epidemiological study. Arthritis Rheum 35: 588
Pachman LM, Callen AM, Hayford J et al. (1994) Juvenile dermatomyositis (JDMS): decreased calcinosis with intermittend high dose intravenous methylprednisolone (IV pulses) therapy. Arthritis Rheum 37: S429
Pachman LM, Hayford JR, Hochberg MC et al. (1997) New-onset juvenile dermatomyositis: Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum 40: 1526–1533
Pachman LM, Hayford JR, Chung A et al. (1998) Juvenile dermatomyositis at diagnosis Clinical characteristics of 79 children. J Rheumatol 25: 1198–1204
Pachman LM, Liotta-Davis MR, Hong DK et al. (2000) TNFalpha-308A allele in juvenile dermatomyositis association with increased production of tumor necrosisfactor alpha, disease duration, and pathologic calcification. Arthr Rheum 43: 2368–2377
Park JH, Niermann KJ, Ryder NM, Nelson AE, Das A, Lawton AR, Hernanz-Schulman M, Olsen NJ (2000) Muscle abnormalities in juvenile dermatomyositis patients. Arthritis Rheum 43: 2359–2367
Prieur AM (ed) (1999) Rhumatologie pédiatrique. Flammarion, Paris
Ramanan AV, Campbell-Webster N, Ota S et al. (2005) The eff ectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum 52: 3570–3578
Reed AM, Pachman I, Ober C (1991) Molecular genetic studies of major histocompatibility complex genes in children with juvenile dermatomyositis: increased risk associated with HLA-DQAI’0501. Hum Immunol 32: 235–240
Reed AM, Pachman LM, Hayford J et al. (1998) Immunogenetic studies in families of children with juvenile dermatomyositis. J Rheumatol 25: 1000–1002
Reed AM, Picornell YJ, Harwood A et al. (2000) Chimerism in children with juvenile dermatomyositis. Lancet 356: 2156–2157
Reed AM, Lopez M. (2002) Juvenile dermatomyositis: recognititon and treatment. Paediatr Drugs 4: 315–321
Reed AM, McNallan K, Wettstein P et al. (2004) Does HLA-dependent chimerism underlie the pathogenesis of juvenile dermatomyositis. J Immunol 172: 5041–5046
Reiff A, Rawlings DJ, Shaham B et al. (1997) Preliminary evidence for cyclosporine A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 24: 2436–2443
Ruperto N, Ravelli A, Murray KJ et al. for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG) (2003) Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematodes and juvenile dermatomyositis. Rheumatology 42: 1452
Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85: 41
Sullivan DB, Cassidy JT, Petty RE (1977) Dermatomyositis in the pediatric patient. Arthritis Rheum 20: 327–331
Summers RM, Brune AM, Choyke PL et al. (1998) Juvenile idiopathic inflammatory myopathy: exercise-induced changes in muscle at short inversion time inversion-recovery MR imaging. Radiology 209: 191–196
Symmons DP, Sills JA, Davis SM (1995) The incidence of juvenile dermatomyositis results from a nation-wide study. Br J Rheumatol 34: 732–736
Taieb A, Guichard C, Salamon R, Maleville J (1985) Prognosis in juvenile dermatopolymyositis: a cooperative terospective study of 70 cases. Pediatr Dermatol 2: 275–281
Targoff IN (2002) Laboratory testing in the diagnosis of idiopathic in-fl ammatory myopathies. Rheum Dis Clin N Am 28: 859–890
Tezak Z, Hoffman EP, Lutz JL et al. (2002) Gene expression profi ling in DQAI’0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154–4163
Uzel G, Pachman LM (2003) Cytokines in juvenile dermatomyositis pathophysiology: potential and challenge. Curr Opin Rheumatol 15: 691–697
Vavrincova P, Havelka S, Cerna M et al. (1993) HLA class II alleles in juvenile dermatomyositis. J Rheumatol 37(Suppl): 17–18
Webster AD, Tripp JH, Hayward AR et al. (1978) Echovirus encephalitis and myositis in primary immunoglobulin deficiency. Arch Dis Child 53: 33
Yoshimasu T, Ohtani T, Sakamoto T et al. (2002) Topical FK 506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 12: 50–52
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Thon, A., Gahr, M. (2007). Dermatomyositis. In: Wagner, N., Dannecker, G. (eds) Pädiatrische Rheumatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-32815-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-32815-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-32814-8
Online ISBN: 978-3-540-32815-5
eBook Packages: Medicine (German Language)